Once-weekly semaglutide in adults with overweight or obesity Summary: The STEP 1 trial showed a mean weight loss of 14.9% with once-weekly subcutaneous semaglutide 2.4 mg in individuals with overweight or obesity without type 2 diabetes
In the multicenter, randomized, placebo-controlled Q-SYMBIO trial, a daily CoQ10 intake of 300mg was found to significantly reduce the incidence of a major adverse cardiovascular event in 15% of subjects (63 out of 420 participants),57 and a 2025 meta-analysis determined that long-term supplementation with doses as low as 100mg significantly reduced users systolic blood pressure.58 IM8 has perhaps too little CoQ10 to make a noticeable difference in, say, heart attack risk, but it seems well-dosed for people looking to alleviate hypertension
The hairs shed via telogen effluvium look like normal hairs, with a standard hair shaft thickness
Your goals, our medical expertiseright here at home
L-carnitine is an amino-acid derivative that plays a critical role in energy production
